Table of Content

1 Study Coverage
1.1 Montelukast Drug Product Introduction
1.2 Market by Type
1.2.1 Global Montelukast Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablets
1.2.3 Oral Granules
1.3 Market by Application
1.3.1 Global Montelukast Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Montelukast Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Montelukast Drug Revenue by Region
2.2.1 Global Montelukast Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Montelukast Drug Revenue by Region (2018-2024)
2.2.3 Global Montelukast Drug Revenue by Region (2024-2029)
2.2.4 Global Montelukast Drug Revenue Market Share by Region (2018-2029)
2.3 Global Montelukast Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Montelukast Drug Sales by Region
2.4.1 Global Montelukast Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Montelukast Drug Sales by Region (2018-2024)
2.4.3 Global Montelukast Drug Sales by Region (2024-2029)
2.4.4 Global Montelukast Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Montelukast Drug Sales by Manufacturers
3.1.1 Global Montelukast Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Montelukast Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Montelukast Drug in 2022
3.2 Global Montelukast Drug Revenue by Manufacturers
3.2.1 Global Montelukast Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Montelukast Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Montelukast Drug Revenue in 2022
3.3 Global Key Players of Montelukast Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Montelukast Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Montelukast Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Montelukast Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Montelukast Drug, Product Offered and Application
3.8 Global Key Manufacturers of Montelukast Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Montelukast Drug Sales by Type
4.1.1 Global Montelukast Drug Historical Sales by Type (2018-2024)
4.1.2 Global Montelukast Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Montelukast Drug Sales Market Share by Type (2018-2029)
4.2 Global Montelukast Drug Revenue by Type
4.2.1 Global Montelukast Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Montelukast Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Montelukast Drug Revenue Market Share by Type (2018-2029)
4.3 Global Montelukast Drug Price by Type
4.3.1 Global Montelukast Drug Price by Type (2018-2024)
4.3.2 Global Montelukast Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Montelukast Drug Sales by Application
5.1.1 Global Montelukast Drug Historical Sales by Application (2018-2024)
5.1.2 Global Montelukast Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Montelukast Drug Sales Market Share by Application (2018-2029)
5.2 Global Montelukast Drug Revenue by Application
5.2.1 Global Montelukast Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Montelukast Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Montelukast Drug Revenue Market Share by Application (2018-2029)
5.3 Global Montelukast Drug Price by Application
5.3.1 Global Montelukast Drug Price by Application (2018-2024)
5.3.2 Global Montelukast Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Montelukast Drug Market Size by Type
6.1.1 US & Canada Montelukast Drug Sales by Type (2018-2029)
6.1.2 US & Canada Montelukast Drug Revenue by Type (2018-2029)
6.2 US & Canada Montelukast Drug Market Size by Application
6.2.1 US & Canada Montelukast Drug Sales by Application (2018-2029)
6.2.2 US & Canada Montelukast Drug Revenue by Application (2018-2029)
6.3 US & Canada Montelukast Drug Market Size by Country
6.3.1 US & Canada Montelukast Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Montelukast Drug Sales by Country (2018-2029)
6.3.3 US & Canada Montelukast Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Montelukast Drug Market Size by Type
7.1.1 Europe Montelukast Drug Sales by Type (2018-2029)
7.1.2 Europe Montelukast Drug Revenue by Type (2018-2029)
7.2 Europe Montelukast Drug Market Size by Application
7.2.1 Europe Montelukast Drug Sales by Application (2018-2029)
7.2.2 Europe Montelukast Drug Revenue by Application (2018-2029)
7.3 Europe Montelukast Drug Market Size by Country
7.3.1 Europe Montelukast Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Montelukast Drug Sales by Country (2018-2029)
7.3.3 Europe Montelukast Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Montelukast Drug Market Size
8.1.1 China Montelukast Drug Sales (2018-2029)
8.1.2 China Montelukast Drug Revenue (2018-2029)
8.2 China Montelukast Drug Market Size by Application
8.2.1 China Montelukast Drug Sales by Application (2018-2029)
8.2.2 China Montelukast Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Montelukast Drug Market Size by Type
9.1.1 Asia Montelukast Drug Sales by Type (2018-2029)
9.1.2 Asia Montelukast Drug Revenue by Type (2018-2029)
9.2 Asia Montelukast Drug Market Size by Application
9.2.1 Asia Montelukast Drug Sales by Application (2018-2029)
9.2.2 Asia Montelukast Drug Revenue by Application (2018-2029)
9.3 Asia Montelukast Drug Sales by Region
9.3.1 Asia Montelukast Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Montelukast Drug Revenue by Region (2018-2029)
9.3.3 Asia Montelukast Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Montelukast Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Montelukast Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Montelukast Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Montelukast Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Montelukast Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Montelukast Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Montelukast Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Montelukast Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Montelukast Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Montelukast Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Information
11.1.2 Merck & Co. Overview
11.1.3 Merck & Co. Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck & Co. Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck & Co. Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Teva Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Overview
11.3.3 Mylan Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Mylan Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Glenmark Pharmaceuticals
11.4.1 Glenmark Pharmaceuticals Company Information
11.4.2 Glenmark Pharmaceuticals Overview
11.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Glenmark Pharmaceuticals Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Glenmark Pharmaceuticals Recent Developments
11.5 Hikma Group
11.5.1 Hikma Group Company Information
11.5.2 Hikma Group Overview
11.5.3 Hikma Group Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Hikma Group Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hikma Group Recent Developments
11.6 Sandoz
11.6.1 Sandoz Company Information
11.6.2 Sandoz Overview
11.6.3 Sandoz Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sandoz Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sandoz Recent Developments
11.7 Torrent Pharmaceuticals
11.7.1 Torrent Pharmaceuticals Company Information
11.7.2 Torrent Pharmaceuticals Overview
11.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Torrent Pharmaceuticals Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Torrent Pharmaceuticals Recent Developments
11.8 Lannett Company
11.8.1 Lannett Company Company Information
11.8.2 Lannett Company Overview
11.8.3 Lannett Company Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Lannett Company Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lannett Company Recent Developments
11.9 Apotex
11.9.1 Apotex Company Information
11.9.2 Apotex Overview
11.9.3 Apotex Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Apotex Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Apotex Recent Developments
11.10 Dr. Reddys Laboratories
11.10.1 Dr. Reddys Laboratories Company Information
11.10.2 Dr. Reddys Laboratories Overview
11.10.3 Dr. Reddys Laboratories Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Dr. Reddys Laboratories Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Dr. Reddys Laboratories Recent Developments
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Information
11.11.2 Aurobindo Pharma Overview
11.11.3 Aurobindo Pharma Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Aurobindo Pharma Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Aurobindo Pharma Recent Developments
11.12 Accord Healthcare
11.12.1 Accord Healthcare Company Information
11.12.2 Accord Healthcare Overview
11.12.3 Accord Healthcare Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Accord Healthcare Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Accord Healthcare Recent Developments
11.13 Hetero
11.13.1 Hetero Company Information
11.13.2 Hetero Overview
11.13.3 Hetero Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Hetero Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hetero Recent Developments
11.14 Unimark
11.14.1 Unimark Company Information
11.14.2 Unimark Overview
11.14.3 Unimark Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Unimark Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Unimark Recent Developments
11.15 Ajanta Pharma
11.15.1 Ajanta Pharma Company Information
11.15.2 Ajanta Pharma Overview
11.15.3 Ajanta Pharma Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Ajanta Pharma Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Ajanta Pharma Recent Developments
11.16 MACLEODS
11.16.1 MACLEODS Company Information
11.16.2 MACLEODS Overview
11.16.3 MACLEODS Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 MACLEODS Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 MACLEODS Recent Developments
11.17 Jubilant Pharma
11.17.1 Jubilant Pharma Company Information
11.17.2 Jubilant Pharma Overview
11.17.3 Jubilant Pharma Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Jubilant Pharma Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Jubilant Pharma Recent Developments
11.18 Unichem Laboratories
11.18.1 Unichem Laboratories Company Information
11.18.2 Unichem Laboratories Overview
11.18.3 Unichem Laboratories Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Unichem Laboratories Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Unichem Laboratories Recent Developments
11.19 Amneal Pharmaceuticals
11.19.1 Amneal Pharmaceuticals Company Information
11.19.2 Amneal Pharmaceuticals Overview
11.19.3 Amneal Pharmaceuticals Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Amneal Pharmaceuticals Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Amneal Pharmaceuticals Recent Developments
11.20 Shanghai Anbison Lab
11.20.1 Shanghai Anbison Lab Company Information
11.20.2 Shanghai Anbison Lab Overview
11.20.3 Shanghai Anbison Lab Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Shanghai Anbison Lab Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Shanghai Anbison Lab Recent Developments
11.21 Perrigo
11.21.1 Perrigo Company Information
11.21.2 Perrigo Overview
11.21.3 Perrigo Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 Perrigo Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Perrigo Recent Developments
11.22 Cipla
11.22.1 Cipla Company Information
11.22.2 Cipla Overview
11.22.3 Cipla Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.22.4 Cipla Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Cipla Recent Developments
11.23 CSPC Ouyi Pharmaceutical
11.23.1 CSPC Ouyi Pharmaceutical Company Information
11.23.2 CSPC Ouyi Pharmaceutical Overview
11.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 CSPC Ouyi Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Montelukast Drug Industry Chain Analysis
12.2 Montelukast Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Montelukast Drug Production Mode & Process
12.4 Montelukast Drug Sales and Marketing
12.4.1 Montelukast Drug Sales Channels
12.4.2 Montelukast Drug Distributors
12.5 Montelukast Drug Customers
13 Market Dynamics
13.1 Montelukast Drug Industry Trends
13.2 Montelukast Drug Market Drivers
13.3 Montelukast Drug Market Challenges
13.4 Montelukast Drug Market Restraints
14 Key Findings in The Global Montelukast Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Montelukast Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Oral Granules
Table 4. Global Montelukast Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Montelukast Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Montelukast Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Montelukast Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Montelukast Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Montelukast Drug Revenue Market Share by Region (2024-2029)
Table 10. Global Montelukast Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Montelukast Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Montelukast Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global Montelukast Drug Sales Market Share by Region (2018-2024)
Table 14. Global Montelukast Drug Sales Market Share by Region (2024-2029)
Table 15. Global Montelukast Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Montelukast Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Montelukast Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Montelukast Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Montelukast Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Montelukast Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Montelukast Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Montelukast Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Drug as of 2022)
Table 23. Global Key Manufacturers of Montelukast Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Montelukast Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Montelukast Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Montelukast Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Montelukast Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global Montelukast Drug Sales Share by Type (2018-2024)
Table 30. Global Montelukast Drug Sales Share by Type (2024-2029)
Table 31. Global Montelukast Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Montelukast Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Montelukast Drug Revenue Share by Type (2018-2024)
Table 34. Global Montelukast Drug Revenue Share by Type (2024-2029)
Table 35. Montelukast Drug Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Montelukast Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Montelukast Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Montelukast Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global Montelukast Drug Sales Share by Application (2018-2024)
Table 40. Global Montelukast Drug Sales Share by Application (2024-2029)
Table 41. Global Montelukast Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Montelukast Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Montelukast Drug Revenue Share by Application (2018-2024)
Table 44. Global Montelukast Drug Revenue Share by Application (2024-2029)
Table 45. Montelukast Drug Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Montelukast Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Montelukast Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Montelukast Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Montelukast Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Montelukast Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Montelukast Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Montelukast Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Montelukast Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Montelukast Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Montelukast Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Montelukast Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Montelukast Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe Montelukast Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Montelukast Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe Montelukast Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Montelukast Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Montelukast Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Montelukast Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe Montelukast Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Montelukast Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Montelukast Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Montelukast Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Montelukast Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 73. China Montelukast Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Montelukast Drug Sales by Type (2024-2029) & (K Units)
Table 75. China Montelukast Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Montelukast Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Montelukast Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Montelukast Drug Sales by Application (2024-2029) & (K Units)
Table 79. China Montelukast Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Montelukast Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Montelukast Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Montelukast Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia Montelukast Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Montelukast Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Montelukast Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Montelukast Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia Montelukast Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Montelukast Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Montelukast Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Montelukast Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Montelukast Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Montelukast Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Montelukast Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Montelukast Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Montelukast Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Montelukast Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Montelukast Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Montelukast Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Montelukast Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Montelukast Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Montelukast Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Montelukast Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Montelukast Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Montelukast Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 107. Merck & Co. Company Information
Table 108. Merck & Co. Description and Major Businesses
Table 109. Merck & Co. Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Merck & Co. Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck & Co. Recent Developments
Table 112. Teva Company Information
Table 113. Teva Description and Major Businesses
Table 114. Teva Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Teva Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva Recent Developments
Table 117. Mylan Company Information
Table 118. Mylan Description and Major Businesses
Table 119. Mylan Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Mylan Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Mylan Recent Developments
Table 122. Glenmark Pharmaceuticals Company Information
Table 123. Glenmark Pharmaceuticals Description and Major Businesses
Table 124. Glenmark Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Glenmark Pharmaceuticals Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Glenmark Pharmaceuticals Recent Developments
Table 127. Hikma Group Company Information
Table 128. Hikma Group Description and Major Businesses
Table 129. Hikma Group Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Hikma Group Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Hikma Group Recent Developments
Table 132. Sandoz Company Information
Table 133. Sandoz Description and Major Businesses
Table 134. Sandoz Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Sandoz Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Sandoz Recent Developments
Table 137. Torrent Pharmaceuticals Company Information
Table 138. Torrent Pharmaceuticals Description and Major Businesses
Table 139. Torrent Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Torrent Pharmaceuticals Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Torrent Pharmaceuticals Recent Developments
Table 142. Lannett Company Company Information
Table 143. Lannett Company Description and Major Businesses
Table 144. Lannett Company Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Lannett Company Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Lannett Company Recent Developments
Table 147. Apotex Company Information
Table 148. Apotex Description and Major Businesses
Table 149. Apotex Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Apotex Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Apotex Recent Developments
Table 152. Dr. Reddys Laboratories Company Information
Table 153. Dr. Reddys Laboratories Description and Major Businesses
Table 154. Dr. Reddys Laboratories Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Dr. Reddys Laboratories Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Dr. Reddys Laboratories Recent Developments
Table 157. Aurobindo Pharma Company Information
Table 158. Aurobindo Pharma Description and Major Businesses
Table 159. Aurobindo Pharma Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Aurobindo Pharma Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Aurobindo Pharma Recent Developments
Table 162. Accord Healthcare Company Information
Table 163. Accord Healthcare Description and Major Businesses
Table 164. Accord Healthcare Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Accord Healthcare Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Accord Healthcare Recent Developments
Table 167. Hetero Company Information
Table 168. Hetero Description and Major Businesses
Table 169. Hetero Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Hetero Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Hetero Recent Developments
Table 172. Unimark Company Information
Table 173. Unimark Description and Major Businesses
Table 174. Unimark Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 175. Unimark Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Unimark Recent Developments
Table 177. Ajanta Pharma Company Information
Table 178. Ajanta Pharma Description and Major Businesses
Table 179. Ajanta Pharma Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 180. Ajanta Pharma Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Ajanta Pharma Recent Developments
Table 182. MACLEODS Company Information
Table 183. MACLEODS Description and Major Businesses
Table 184. MACLEODS Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 185. MACLEODS Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. MACLEODS Recent Developments
Table 187. Jubilant Pharma Company Information
Table 188. Jubilant Pharma Description and Major Businesses
Table 189. Jubilant Pharma Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 190. Jubilant Pharma Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Jubilant Pharma Recent Developments
Table 192. Unichem Laboratories Company Information
Table 193. Unichem Laboratories Description and Major Businesses
Table 194. Unichem Laboratories Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 195. Unichem Laboratories Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Unichem Laboratories Recent Developments
Table 197. Amneal Pharmaceuticals Company Information
Table 198. Amneal Pharmaceuticals Description and Major Businesses
Table 199. Amneal Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 200. Amneal Pharmaceuticals Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Amneal Pharmaceuticals Recent Developments
Table 202. Shanghai Anbison Lab Company Information
Table 203. Shanghai Anbison Lab Description and Major Businesses
Table 204. Shanghai Anbison Lab Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 205. Shanghai Anbison Lab Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Shanghai Anbison Lab Recent Developments
Table 207. Perrigo Company Information
Table 208. Perrigo Description and Major Businesses
Table 209. Perrigo Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 210. Perrigo Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Perrigo Recent Developments
Table 212. Cipla Company Information
Table 213. Cipla Description and Major Businesses
Table 214. Cipla Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 215. Cipla Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 216. Cipla Recent Developments
Table 217. CSPC Ouyi Pharmaceutical Company Information
Table 218. CSPC Ouyi Pharmaceutical Description and Major Businesses
Table 219. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 220. CSPC Ouyi Pharmaceutical Montelukast Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 221. CSPC Ouyi Pharmaceutical Recent Developments
Table 222. Key Raw Materials Lists
Table 223. Raw Materials Key Suppliers Lists
Table 224. Montelukast Drug Distributors List
Table 225. Montelukast Drug Customers List
Table 226. Montelukast Drug Market Trends
Table 227. Montelukast Drug Market Drivers
Table 228. Montelukast Drug Market Challenges
Table 229. Montelukast Drug Market Restraints
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources
List of Figures
Figure 1. Montelukast Drug Product Picture
Figure 2. Global Montelukast Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Montelukast Drug Market Share by Type in 2022 & 2029
Figure 4. Tablets Product Picture
Figure 5. Oral Granules Product Picture
Figure 6. Global Montelukast Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Montelukast Drug Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Others
Figure 11. Montelukast Drug Report Years Considered
Figure 12. Global Montelukast Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Montelukast Drug Revenue 2018-2029 (US$ Million)
Figure 14. Global Montelukast Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Montelukast Drug Revenue Market Share by Region (2018-2029)
Figure 16. Global Montelukast Drug Sales 2018-2029 ((K Units)
Figure 17. Global Montelukast Drug Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Montelukast Drug Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Montelukast Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Montelukast Drug Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Montelukast Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Montelukast Drug Sales YoY (2018-2029) & (K Units)
Figure 23. China Montelukast Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Montelukast Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Montelukast Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Montelukast Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Montelukast Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Montelukast Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Montelukast Drug in the World: Market Share by Montelukast Drug Revenue in 2022
Figure 30. Global Montelukast Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Montelukast Drug Sales Market Share by Type (2018-2029)
Figure 32. Global Montelukast Drug Revenue Market Share by Type (2018-2029)
Figure 33. Global Montelukast Drug Sales Market Share by Application (2018-2029)
Figure 34. Global Montelukast Drug Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Montelukast Drug Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Montelukast Drug Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Montelukast Drug Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Montelukast Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Montelukast Drug Revenue Share by Country (2018-2029)
Figure 40. US & Canada Montelukast Drug Sales Share by Country (2018-2029)
Figure 41. U.S. Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Montelukast Drug Sales Market Share by Type (2018-2029)
Figure 44. Europe Montelukast Drug Revenue Market Share by Type (2018-2029)
Figure 45. Europe Montelukast Drug Sales Market Share by Application (2018-2029)
Figure 46. Europe Montelukast Drug Revenue Market Share by Application (2018-2029)
Figure 47. Europe Montelukast Drug Revenue Share by Country (2018-2029)
Figure 48. Europe Montelukast Drug Sales Share by Country (2018-2029)
Figure 49. Germany Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 50. France Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 54. China Montelukast Drug Sales Market Share by Type (2018-2029)
Figure 55. China Montelukast Drug Revenue Market Share by Type (2018-2029)
Figure 56. China Montelukast Drug Sales Market Share by Application (2018-2029)
Figure 57. China Montelukast Drug Revenue Market Share by Application (2018-2029)
Figure 58. Asia Montelukast Drug Sales Market Share by Type (2018-2029)
Figure 59. Asia Montelukast Drug Revenue Market Share by Type (2018-2029)
Figure 60. Asia Montelukast Drug Sales Market Share by Application (2018-2029)
Figure 61. Asia Montelukast Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Montelukast Drug Revenue Share by Region (2018-2029)
Figure 63. Asia Montelukast Drug Sales Share by Region (2018-2029)
Figure 64. Japan Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 68. India Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Montelukast Drug Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Montelukast Drug Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Montelukast Drug Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Montelukast Drug Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Montelukast Drug Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Montelukast Drug Sales Share by Country (2018-2029)
Figure 75. Brazil Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Montelukast Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Montelukast Drug Value Chain
Figure 81. Montelukast Drug Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed